Risk of Changes to the Strategic Partnership with Medipal
First written in FY2018-Q2. 2 of 3 entries say "Restated". Latest entry: FY2019.
The whole theme swung hardest in 2023: 4 of 18 companies on the "Worse" side.
31 other companies' latest entry also says "Restated".
- FY2019RestatedAnnual report
「We intend to maintain our strategic alliance with the company and work to further enhance the corporate value of both companies. However, if the strategic alliance with the company changes for any reason, this could have a material impact on our group’s results of operations and financial position.」
The company reconfirmed the risk that changes to its strategic alliance with Medipal could affect results of operations and financial position. - FY2018RestatedAnnual report
「We intend to maintain our strategic alliance with the company and work to further enhance the corporate value of both companies. However, if the strategic alliance with the company changes for any reason, this could have a material impact on our group’s results of operations and financial position.」
The company reconfirmed the risk that changes to its strategic alliance with Medipal could affect results of operations and financial position. - FY2018-Q2First statedAnnual report
「We intend to maintain our strategic alliance with the company and work to further enhance the corporate value of both companies. However, if the strategic alliance with the company changes for any reason, this could have a material impact on our results of operations and financial position.」
The company newly identified as a risk the impact on results of operations and financial position if the alliance changes, assuming the business and capital alliance and joint clinical development with Medipal.